Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Patent
1995-06-05
1997-11-04
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
424 9, 435 723, 43524027, 53038835, 5303897, 5303913, A61K 5100, A61M 3614, G01N 33574, C07K 1600
Patent
active
056836740
ABSTRACT:
Antibodies which bind to the core protein of the human polymorphic epithelial mucin glycoprotein are useful in the diagnosis of cancer.
REFERENCES:
Washington Post, Jan. 18, 1993, Centocon Stops Trails of Flagship Drug.
Gibbs, Scientific American Jul. 1993 101-103.
Griffiths et al, Int J. Cancer 40: 319-327, 1987.
Mather et al Journal of Immunological Methods.
Burchell Joy
Gendler Sandra
Taylor-Papadimitriou Joyce
Cooper Iver P.
Ebert Ray F.
Imperial Cancer Research Technology Ltd.
Knode Marian C.
LandOfFree
Antibody against human mucin core protein and method of preparin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody against human mucin core protein and method of preparin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody against human mucin core protein and method of preparin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1830852